SCHEMBL9943433

SCHEMBL9943433

CC(C)(C)[Si](C)(C)OCC(=CC(=O)O)c1ccc(F)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
MAPT P10636 1/20 0.35
LMNA P02545 1/20 0.34
BTN3A1 O00481 4/20 0.34
NR4A2 P43354 2/20 0.33
NR4A1 P22736 1/20 0.33
NR4A3 Q92570 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDPK1 O15530 1/20 0.33
BCL2L1 Q07817 1/20 0.33
BAD Q92934 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
HTR7 P34969 1/20 0.32
PLOD2 O00469 1/20 0.32
PTPN1 P18031 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9943432 1.00 ADRB2 (0.36) ADRB2ADRB1ADRB3MAPTLMNA
SCHEMBL11920542 0.85 KMT2A (0.38) ADRB2ADRB1ADRB3MAPTLMNA
SCHEMBL11907845 0.85 KMT2A (0.38) ADRB2ADRB1ADRB3MAPTLMNA
SCHEMBL11920540 0.85 KMT2A (0.38) ADRB2ADRB1ADRB3MAPTLMNA
SCHEMBL9943465 0.82 LMNA (0.37) ADRB2ADRB1ADRB3LMNABTN3A1
SCHEMBL9943463 0.82 LMNA (0.37) ADRB2ADRB1ADRB3LMNABTN3A1
SCHEMBL9943640 0.82 LMNA (0.37) ADRB2ADRB1ADRB3LMNABTN3A1
SCHEMBL9943524 0.81 LMNA (0.33) ADRB2ADRB1ADRB3LMNABTN3A1
SCHEMBL9943652 0.81 LMNA (0.33) ADRB2ADRB1ADRB3LMNABTN3A1
SCHEMBL9943525 0.81 LMNA (0.33) ADRB2ADRB1ADRB3LMNABTN3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465847-B1 AZETIDINONE COMPOUNDS AND MEDICAL USE THEREOF ZHEJIANG HISUN PHARM CO LTD (CN) 2016-10-12 EP disclosed
US-8623855-B2 Azetidinone compounds and medical use thereof ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2014-01-07 US disclosed
US-20120208994-A1 AZETIDINONE COMPOUNDS AND MEDICAL USE THEREOF ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2012-08-16 US disclosed
EP-2465847-A1 AZETIDINONE COMPOUNDS AND MEDICAL USE THEREOF Zhejiang Hisun Pharmaceutical Co. Ltd. (CN) 2012-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208994-A1 AZETIDINONE COMPOUNDS AND MEDICAL USE THEREOF CYP46A1, APOB, CETP ADRB2 350/4885ADRB1 142/4885ADRB3 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.